Evidence map›Paper›PMID 38110636›Full record

ArticleNature methods2024

A data analysis framework for combining multiple batches increases the power of isobaric proteomics experiments.

Jonathon J O'Brien, Anil Raj, Aleksandr Gaun, Adam Waite, Wenzhou Li, David G Hendrickson, Niclas Olsson, Fiona E McAllister

Abstract read
PubMed Publisher
In one paragraph

Article in Nature methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jonathon J O'BrienCalico Life Sciences LLC, South San Francisco, CA, USA. obrien@golgistat.com.ORCID http://orcid.org/0000-0001-9660-4797
Anil RajCalico Life Sciences LLC, South San Francisco, CA, USA.
Aleksandr GaunCalico Life Sciences LLC, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-9008-4652
Adam WaiteCalico Life Sciences LLC, South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-3537-7313
Wenzhou LiCalico Life Sciences LLC, South San Francisco, CA, USA.
David G HendricksonCalico Life Sciences LLC, South San Francisco, CA, USA.
Niclas OlssonCalico Life Sciences LLC, South San Francisco, CA, USA.
Fiona E McAllisterCalico Life Sciences LLC, South San Francisco, CA, USA. fiona@calicolabs.com.ORCID http://orcid.org/0000-0002-7862-6711

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a framework for the analysis of multiplexed mass spectrometry proteomics data that reduces estimation error when combining multiple isobaric batches. Variations in the number and quality of observations have long complicated the analysis of isobaric proteomics data. Here we show that the power to detect statistical associations is substantially improved by utilizing models that directly account for known sources of variation in the number and quality of observations that occur across batches.In a multibatch benchmarking experiment, our open-source software (msTrawler) increases the power to detect changes, especially in the range of less than twofold changes, while simultaneously increasing quantitative proteome coverage by utilizing more low-signal observations. Further analyses of previously published multiplexed datasets of 4 and 23 batches highlight both increased power and the ability to navigate complex missing data patterns without relying on unverifiable imputations or discarding reliable measurements.

Indexed as

ProteomicsSoftwareMass SpectrometryProteomeProteome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.